Featured post

родрооிро┤் родிро░ைрок்рокроЯ родропாро░ிрок்рокாро│ро░்роХро│் роЪроЩ்роХрод்родிрой் рооூрод்род роЙро▒ுрок்рокிройро░ுроо், рооுрой்ройாро│் родро▓ைро╡ро░ுрооாрой родிро░ு. роОро╕். роП. роЪрои்родிро░роЪேроХро░рой்

 родрооிро┤் родிро░ைрок்рокроЯ родропாро░ிрок்рокாро│ро░்роХро│் роЪроЩ்роХрод்родிрой் рооூрод்род роЙро▒ுрок்рокிройро░ுроо், рооுрой்ройாро│் родро▓ைро╡ро░ுрооாрой родிро░ு. роОро╕். роП. роЪрои்родிро░роЪேроХро░рой் роЕро╡ро░்роХро│ை рооро░ிропாродை роиிрооிрод்родрооாроХ, роЪроЩ்...

Showing posts with label apollo hospitals group. Show all posts
Showing posts with label apollo hospitals group. Show all posts

Wednesday, 26 April 2023

Apollo announces expansion of its

             Apollo announces expansion of its Genomics Institute

 

With the launch of Apollo Genomics Institute in Chennai, Apollo continues to invest in genomics technology and research for better patient care~

 

Apollo, the world’s largest vertically integrated healthcare provider, today announced the expansion of the Apollo Genomics Institute with the launch of the facility in Chennai. Doubling down on its investments in genomics, Apollo Genomic Institute was earlier launched in Mumbai and Delhi. By the end of 2023, Apollo aims to open three more genomics facilities in Hyderabad, Bangalore and Ahmedabad respectively.



 

India has made huge progress in terms of combating communicable diseases over the years; however, the increase in the number of genetic disorders in the recent past have been overlooked. With genomics, these diseases can be identified before they manifest; in turn, enabling early intervention and preventive care. The Apollo Genomics Institute aims to transform medical practice by bringing genomic services within the reach of every clinician & patient.

 

The Apollo Genomic Institute in Chennai will host a range of genomic services including genetic evaluation, clinical diagnostics, obstetric genetics, cancer genomics, prenatal genetic screening capabilities and more, empowering patients with information to manage and prevent genetic disorders.

 

Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Group, said “India is a highly diverse heterogeneous country, and as a result, genomic medicine could have transformative potential. With decreasing infant mortality rates, genetic disorders are emerging as an important group of diseases. According to a 2021 report by the Ministry of Health and Family Welfare, the number of diseases in India that are globally recognized as rare diseases encompass from around 7,000 to 8,000 disorders. Today, as our population gets more health conscious, we’re also seeing increased awareness amongst individuals around the value of genomic tests in the prevention and diagnosis of non-communicable diseases (NCDs) and genetic diseases such as diabetes, cancer, and cardiovascular disorders amongst others. The expansion of the Genomics Institute is a critical step towards the prevention and management of NCDs, which continues to be a significant public health challenge in India and around the world”.

Ms. Suneeta Reddy, MD, Apollo Hospitals Group, said “At Apollo, we believe that patients need to be brought to the forefront of the decision-making process with regard to their health journey. Constantly increasing availability of real-world data sources coupled with patient-centric analytics offer deeper insights into how they are diagnosed, treated and beyond. Genomics is one such area. On the back of increasing NCDs, the greater availability of patient-level data helps practitioners better understand the patient journey. This also enables personalization in medicine by leveraging genetic insights is immensely impacting decisions made regarding the prevention, diagnosis, and treatment of diseases. At Apollo Genomics Institute, our focus on preventive care and personalized medicine underscores our commitment to a more resilient and healthier society.” 

India has 20 per cent of the world's global population, it only contributes to 0.2 per cent of the global genetic database. Apollo Genomic Network is planning to launch a genomic variant database to collate and secure the genomic data generated in a secure manner.  The Pan-Apollo Genomics Network is also actively involved in academics and research activities. AGI holds weekly case discussions, peer-to-peer learning, monthly Grand rounds and Journal club and Healthcare Seminar series.  As NCDs continue to be one of the leading causes of death and suffering, contributing to 65 per cent of deaths in India, Apollo is committed to making preventive healthcare a national priority. The Apollo Genomics Institutes ultimate goal is to transform the future of healthcare in India by providing access to precision & personalized medical care.

Thursday, 22 October 2020

Apollo Hospitals launches Post Covid Recovery Clinics

APOLLO HOSPITALS LAUNCHES POST-COVID RECOVERY CLINICS ACROSS NETWORK

~ Clinics will help patients who have recovered from COVID but are suffering from persistent effects ~

 The Apollo Hospitals Group today announced the launch of Post-COVID Recovery Clinics across the hospital network. The Post-COVID Recovery Clinics will address the rising number of patients who have recovered from COVID but are suffering from the mid and long term persistent effects of the infection. Over 50% of COVID patients suffer from problems that include breathlessness, chest pain and heart issues, joint pains, vision problems, and memory loss months after contracting the novel coronavirus. The Post-COVID Recovery Clinics will be manned by a team of specialists including neurologists and immunologists to help patients deal with the aftermath of COVID-19 and restore them to health. In Chennai, the Post-COVID Recovery Clinic will be conducted at the Apollo Hospitals Greams Road, Chennai.




 Ms. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group, said, “We had realized early on that addressing the COVID challenge would require a comprehensive response plan and had launched Project Kavach in March, which integrated all aspects from patient education, screening and assessment, testing, to infrastructure for quarantine and treatment. With COVID showing that it has lingering effects in patients who have recovered from the virus infection, it became necessary to add the element of post-recovery care to help recovered patients return to their normal life. We are launching these clinics across the group network in various cities. The Post-COVID Recovery Clinics would be a one-stop shop for patients who have recovered from COVID-19 but still have persistent medical effects and symptoms. The clinics will enable us to provide coordinated care without the patient having to run around to different specialists and avoid duplication of testing that a patient might otherwise undergo.”

Dr. V. Ramasubramanian, Senior Consultant, Infectious Diseases, Apollo Hospitals, said, “Many patients who have recovered from COVID-19 at our hospitals have been contacting us for symptoms that they are having, and not knowing where to go for them. To address these health issues faced by patients who have recovered from COVID-19, we have started the Post-COVID Recovery Clinics. These exclusive clinics for post-COVID care will help patients to connect to the specialised care that they need. We have laid down the guidelines and have trained the clinicians to ensure that patients get the correct treatment. The clinics will help patients recover completely from the consequences of COVID-19 and return to living life as before COVID.”

COVID-19 impacts almost all the vital organs in the body. Apart from acute events like stroke and myocardial infarction, chronic conditions like diabetes and hypertension are part of the post-COVID syndrome. A number of sudden deaths in post-covid patients have been reported and most of these are attributed to acute cardiac events.

Dr. Sundararajan, Senior Consultant Pulmonologist, Apollo Hospitals said, “COVID-19 attacks not just the lungs but other organs in the body and leaves behind lingering health issues. Some of the manifestations occur weeks and months after the treatment for acute phase is completed and patient has recovered and impact the well-being of individuals beyond the acute phase. While longer-term problems are more common among patients who have been hospitalized, even patients who have recovered from a mild case can suffer from the prolonged effects of the virus. Some of the long-term effects may be severe and disabling in nature. This specialized clinic will enable us to monitor symptoms of patients on an ongoing basis and delivery timely medical attention.”

Dr. Suresh, Senior Consultant, Infectious Diseases, Apollo Hospitals said, “Before COVID-19, we were already facing a tsunami of NCDs that were responsible for over 70% of the deaths. The post-COVID syndrome is adding to this disease load and if not addressed with a special focus will lead to an increase in morbidity and mortality beyond the pandemic with a large number of chronically ill individuals who have recovered from COVID. The specialised clinics will prevent acute components of the post-COVID syndrome from progressing further and effectively manage the chronic situations which form part of the post-COVID syndrome through a patient-focused, comprehensive, teleconsult and clinic based program.”

The Post-COVID Recovery Clinics will initially be launched in Apollo hospitals treating COVID in Chennai, Madurai, Hyderabad, Bengaluru, Mysore, Kolkata, Bhubaneswar, Guwahati, Delhi, Indore, Lucknow, Mumbai and Ahmedabad. The clinics will be manned by a dedicated team consisting of a Family Physician assisted by a nurse.

 For appointments, please visit https://www.apollohospitals.com/or call 044-28293333

роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│் роХுро┤ுроороо் родройродு рооро░ுрод்родுро╡рооройைроХро│ிро▓் роХோро╡ிроЯ்-19 роХ்роХு рокிрои்родைроп

роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│் роХுро┤ுроороо் родройродு рооро░ுрод்родுро╡рооройைроХро│ிро▓் роХோро╡ிроЯ்-19 роХ்роХு рокிрои்родைроп родொроЯро░் роЪிроХிроЪ்роЪை рооைропроЩ்роХро│ை роПро▒்рокроЯுрод்родுроХிро▒родு

 ├Ш  роХோро╡ிроЯ் – 19 родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ, роЖройாро▓் родொроЯро░்роЪ்роЪிропாрой ро╡ிро│ைро╡ுроХро│ாро▓் рокாродிроХ்роХрок்рокроЯ்роЯுро│்ро│ роиோропாро│ிроХро│ுроХ்роХு родிро▒роо்рокроЯ்роЯ рооுро▒ைропிро▓் роЪிроХிроЪ்роЪை ро╡ро┤роЩ்роХ роЗрои்род роЪிро▒рок்рокுроХ் роХிро│ிройிроХ்роХுроХро│் роЙродро╡ுроо்


роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│் роХுро┤ுроороо் родройродு рооро░ுрод்родுро╡рооройை ро╡ро▓ைропрооைрок்рокு рооுро┤ுро╡родுроо் роХோро╡ிроЯ் родொро▒்ро▒ுроХ்роХுрок் рокிрои்родைроп роЪிроХிроЪ்роЪைроХ்роХாрой роХிро│ிройிроХ்роХுроХро│ை родொроЯроЩ்роХுро╡родாроХ роЕро▒ிро╡ிрод்родுро│்ро│родு. роХோро╡ிроЯ் родொро▒்ро▒ுроХ்роХுрок் рокிрои்родைроп роЗрои்род роХிро│ிройிроХ்роХுроХро│் роХோро╡ிроЯ் родொро▒்ро▒ுрокாродிрок்рокிро▓ிро░ுрои்родு рооீрог்роЯு ро╡рои்род роЖройாро▓் роиோроп்род்родொро▒்ро▒ாро▓் роПро▒்рокроЯுроо் роироЯுрод்родро░ рооро▒்ро▒ுроо் роиீрог்роЯроХாро▓ ро╡ிро│ைро╡ுроХро│ாро▓் рокாродிроХ்роХрок்рокроЯுроо் роиோропாро│ிроХро│ிрой் роОрог்рогிроХ்роХை роЕродிроХро░ிрод்родு ро╡ро░ுроо் роиிро▓ைропிро▓், роЕро╡ро░்роХро│родு роЪிроХ்роХро▓்роХро│ை роЗрои்род роЪிроХிроЪ்роЪை рооைропроЩ்роХро│் родீро░்роХ்роХுроо்.  роХோро╡ிроЯ்-19 роиோропாро│ிроХро│ிро▓் 50 роЪродро╡ீрод்родுроХ்роХுроо் роЕродிроХрооாройோро░் ро╡ைро░ро╕் родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ рокிрой் роЪிро▓ рооாродроЩ்роХро│ுроХ்роХுрок் рокிро▒роХு рооூроЪ்роЪுрод் родிрогро▒ро▓், роиெроЮ்роЪு ро╡ро▓ி рооро▒்ро▒ுроо் роЗродроп рокிро░роЪ்роЪிройைроХро│், рооூроЯ்роЯு ро╡ро▓ி, рокாро░்ро╡ை рокிро░роЪ்роЪிройைроХро│் рооро▒்ро▒ுроо் роиிройைро╡ாро▒்ро▒ро▓் роЗро┤рок்рокு роЙро│்ро│ிроЯ்роЯ роЪிроХ்роХро▓்роХро│ாро▓் рокாродிроХ்роХрок்рокроЯுроХிрой்ро▒ройро░். роХோро╡ிроЯ்-19 родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ рокிро▒роХு роиோропாро│ிроХро│ுроХ்роХு родொроЯро░் роЪிроХிроЪ்роЪை роЕро│ிроХ்роХро╡ுроо், роЕро╡ро░்роХро│ை роЖро░ோроХ்роХிропрооாроХ рооீроЯ்роЯெроЯுроХ்роХро╡ுроо் роЙродро╡ுроо் ро╡роХைропிро▓், роиро░роо்рокிропро▓் роиிрокுрогро░்роХро│் рооро▒்ро▒ுроо் роиோроп் роОродிро░்рок்рокு роиிрокுрогро░்роХро│் роЙро│்ро│ிроЯ்роЯ роиிрокுрогро░்роХро│ிрой் роХுро┤ுро╡ாро▓் роЗрои்род роХோро╡ிроЯ்-роЯுроХ்роХு рокிрои்родைроп роХிро│ிройிроХ்роХுроХро│் роиிро░்ро╡роХிроХ்роХрок்рокроЯுроХிрой்ро▒рой. роЪெрой்ройைропிро▓், роХிро░ீроо்ро╕்ро░ோроЯு, роЕрок்рокோро▓ோ рооро░ுрод்родுро╡рооройைропிро▓் роХோро╡ிроЯ்-роХ்роХு рокிрои்родைроп роЪிро▒рок்рокுроЪிроХிроЪ்роЪை, рооீроЯ்рокு рооро░ுрод்родுро╡рооройை роЪெропро▓்рокроЯுроо்.

 роЗродு роХுро▒ிрод்родு роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│் роХுро┤ுроород்родிрой் родுрогைрод் родро▓ைро╡ро░் рок்ро░ீродா ро░ெроЯ்роЯி роХூро▒ுроХைропிро▓், "роХோро╡ிроЯ் роЪро╡ாро▓ை роОродிро░்роХொро│்ро╡родро▒்роХு роТро░ு ро╡ிро░ிро╡ாрой роЪிроХிроЪ்роЪை родிроЯ்роЯроо் родேро╡ைрок்рокроЯுроо் роОрой்рокродை роиாроЩ்роХро│் роЖро░роо்рокрод்родிро▓ேропே роЙрогро░்рои்родு, рооாро░்роЪ் рооாродрод்родிро▓ே роХро╡ாроЪ் роОрой்ро▒ родிроЯ்роЯрод்родைрод் родொроЯроЩ்роХிройோроо், роЗродு роиோропாро│ிропிроХ்роХு ро╡ிро┤ிрок்рокுрогро░்ро╡ு роПро▒்рокроЯுрод்родுродро▓், роЖроп்ро╡ு роЪெроп்родро▓், роородிрок்рокீроЯு, роЪோродройை, родройிрооைрок்рокроЯுрод்родро▓் рооро▒்ро▒ுроо் роЪிроХிроЪ்роЪைроХ்роХாрой роЙро│்роХроЯ்роЯрооைрок்рокு ро╡ро░ை роЕройைрод்родு роЕроо்роЪроЩ்роХро│ைропுроо் роТро░ுроЩ்роХிрогைрок்рокродாроХ роЕрооைрои்родродு.

 ро╡ைро░ро╕் родொро▒்ро▒ிро▓ிро░ுрои்родு рооீрог்роЯாро▓ுроо் роЕродு роиீроЯிрод்род ро╡ிро│ைро╡ுроХро│ைроХ் роХொрог்роЯிро░ுрок்рокродாроХ роЕрооைрои்родுро│்ро│родு. роОройро╡ே рооீрог்роЯ роиோропாро│ிроХро│் рооுро┤ுро╡родுроо் роЗропро▓்рокு ро╡ாро┤்роХ்роХைроХ்роХுрод் родிро░ுроо்рокுро╡родро▒்роХு роЙродро╡, рооீроЯ்рокுроХ்роХுрок் рокிрои்родைроп роХро╡ройிрок்рокிрой் роЕроо்роЪроЩ்роХро│் роЕро╡роЪிропрооாройродு. роОройро╡ே роЗродро▒்роХாрой роХிро│ிройிроХ்роХுроХро│ை рокро▓்ро╡ேро▒ு роироХро░роЩ்роХро│ிро▓் роЙро│்ро│ роОроЩ்роХро│родு рооро░ுрод்родுро╡рооройைроХро│ிро▓் родொроЯроЩ்роХுроХிро▒ோроо். роХோро╡ிроЯ் -19-ро▓ிро░ுрои்родு рооீрог்роЯ роЖройாро▓் родொроЯро░்рои்родு ро╡ிро│ைро╡ுроХро│் рооро▒்ро▒ுроо் роЕро▒ிроХுро▒ிроХро│ைроХ் роХொрог்роЯ

  роиோропாро│ிроХро│ுроХ்роХு роЗрои்род роХோро╡ிроЯ்-роЯுроХ்роХுрок் рокிрои்родைроп рооீроЯ்рокு роХிро│ிройிроХ்роХுроХро│் роТро░ே родро│род்родிро▓்рооேроо்рокроЯ்роЯ роЪிроХிроЪ்роЪைроХро│ை ро╡ро┤роЩ்роХுроо் роЪிро▒рои்род роЗроЯрооாроХрод் родிроХро┤ுроо். роиோропாро│ி ро╡ெро╡்ро╡ேро▒ு роиிрокுрогро░்роХро│ிроЯроо் роЪெро▓்ро▓ாрооро▓் роТро░ுроЩ்роХிрогைрои்род роХро╡ройிрок்рокைрок் рокெро▒ро╡ுроо் роЕро╡ро░்роХро│ுроХ்роХு роЪிро▒рои்род роЪிроХிроЪ்роЪை ро╡ро┤роЩ்роХро╡ுроо் роЗрои்род роХிро│ிройிроХ்роХுроХро│் роЙродро╡ுроо். рооேро▓ுроо் роТро░ு роиோропாро│ி рооேро▒்роХொро│்ро│роХ்роХூроЯிроп рокро▓்ро╡ேро▒ு рокро░ிроЪோродройைроХро│ைрод் родро╡ிро░்роХ்роХро╡ுроо் роЗродு роЙродро╡ுроо்.” роОрой்ро▒ாро░்.

 роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைропைроЪ் роЪேро░்рои்род родொро▒்ро▒ு роиோроп் роЪிроХிроЪ்роЪைрок் рокிро░ிро╡ு рооூрод்род роЖро▓ோроЪроХро░் роЯாроХ்роЯро░் ро╡ி.ро░ாроороЪுрок்рокிро░роорогிропрой் роХூро▒ுроХைропிро▓், “роХோро╡ிроЯ் -19-ро▓ிро░ுрои்родு рооீрог்роЯ рокро▓ роиோропாро│ிроХро│், родொроЯро░் роЪிроХ்роХро▓்роХро│் роПро▒்рокроЯுродро╡ாро▓் роОроЩ்роХро│ைрод் родொроЯро░்рокு роХொро│்роХிрой்ро▒ройро░். роЗродро▒்роХு роОроЩ்роХு роЪெро▓்ро▓ ро╡ேрог்роЯுроо் роОрой்ро▒ு роЕро╡ро░்роХро│ுроХ்роХுрод் родெро░ிропро╡ிро▓்ро▓ை. роХோро╡ிроЯ் -19-ро▓ிро░ுрои்родு рооீрог்роЯ роиோропாро│ிроХро│் роОродிро░்роХொро│்ро│ுроо் роЗрои்род роЪுроХாродாро░ рокிро░роЪ்роЪிройைроХро│ுроХ்роХு родீро░்ро╡ு роХாрог, роХோро╡ிроЯ்-роЯுроХ்роХு рокிрои்родைроп рооீроЯ்рокுроХ்роХாрой роЪிроХிроЪ்роЪை роЕро│ிроХ்роХுроо் рооைропроЩ்роХро│ைрод்  (роХிро│ிройிроХ்роХுроХро│்) родொроЯроЩ்роХிропுро│்ро│ோроо். роХோро╡ிроЯ்-роЯுроХ்роХுрок் рокிрои்родைроп рокро░ாрооро░ிрок்рокுроХ்роХாрой роЗрои்род рокிро░род்ропேроХ роХிро│ிройிроХ்роХுроХро│் роиோропாро│ிроХро│ுроХ்роХுрод் родேро╡ைропாрой роЪிро▒рок்рокு роХро╡ройிрок்рокுроХро│ை ро╡ро┤роЩ்роХ роЙродро╡ுроо். роиாроЩ்роХро│் ро╡ро┤ிроХாроЯ்роЯு роиெро▒ிрооுро▒ைроХро│ை ро╡роХுрод்родுро│்ро│родுроЯрой், роиோропாро│ிроХро│் роЪро░ிропாрой роЪிроХிроЪ்роЪைропைрок் рокெро▒ுро╡родை роЙро▒ுродி роЪெроп்роп ро╡ро▓்ро▓ுроиро░்роХро│ுроХ்роХு рокропிро▒்роЪி роЕро│ிрод்родுро│்ро│ோроо். роиோропாро│ிроХро│் роХோро╡ிроЯ்-19 роЗрой் ро╡ிро│ைро╡ுроХро│ிро▓ிро░ுрои்родு рооுро┤ுрооைропாроХ рооீрог்роЯு, роХோро╡ிроЯ்роЯுроХ்роХு рооுрои்родைроп роиிро▓ைропைрок் рокோро▓ро╡ே роЗропро▓்рокு ро╡ாро┤்роХ்роХைроХ்роХு рооுро┤ுрооைропாроХ роЕро╡ро░்роХро│் родிро░ுроо்рок роЗрои்род роХிро│ிройிроХ்роХுроХро│் роЙродро╡ுроо்.” роОрой்ро▒ாро░்.

 роХோро╡ிроЯ்-19 роЙроЯро▓ிро▓் роЙро│்ро│ роЕройைрод்родு рооுроХ்роХிроп роЙро▒ுрок்рокுроХро│ைропுроо் рокாродிроХ்роХிро▒родு. рокроХ்роХро╡ாродроо் рооро▒்ро▒ுроо் рооாро░роЯைрок்рокு рокோрой்ро▒ роХроЯுрооைропாрой роиிроХро┤்ро╡ுроХро│ைрод் родро╡ிро░, роиீро░ிро┤ிро╡ு рооро▒்ро▒ுроо் роЙропро░் роЗро░род்род роЕро┤ுрод்родроо் рокோрой்ро▒ роиாро│்рокроЯ்роЯ роиிро▓ைрооைроХро│் роХோро╡ிроЯ்-роХ்роХுрок் рокிрои்родைроп роиோроп்роХ்роХுро▒ிропிрой் роТро░ு рокроХுродிропாроХுроо். роХோро╡ிроЯ் родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ роиோропாро│ிроХро│ிро▓் роЪிро▓ро░் родிроЯீро░ெрой роЙропிро░ிро┤рои்родுро│்ро│ройро░். роЗро╡ро░்роХро│ிро▓் рокெро░ுроо்рокாро▓ாрой роЙропிро░ிро┤рок்рокுроХро│் роХроЯுрооைропாрой роЗродропроХ் роХோро│ாро▒ாро▓் роПро▒்рокроЯ்роЯுро│்ро│рой.

 роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைропிрой் рооூрод்род роиுро░ைропீро░ро▓் роЪிроХிроЪ்роЪை роиிрокுрогро░் роЯாроХ்роЯро░் роЪுрои்родро░ро░ாроЬрой் роХூро▒ுроХைропிро▓், " роХோро╡ிроЯ் -19 роиுро░ைропீро░ро▓ை роороЯ்роЯுрооро▓்ро▓ாрооро▓், роЙроЯро▓ிро▓் роЙро│்ро│ рооро▒்ро▒ роЙро▒ுрок்рокுроХро│ைропுроо் рокாродிрод்родு роиீроЯிрод்род роЪுроХாродாро░ рокிро░роЪ்роЪிройைроХро│ை роПро▒்рокроЯுрод்родுроХிро▒родு. роХோро╡ிроЯ்-19 родொро▒்ро▒ிрой் роХроЯுрооைропாрой роХроЯ்роЯрод்родிро▒்роХாрой роЪிроХிроЪ்роЪை рооுроЯிрои்родродுроо், роиோропாро│ி роХுрогроороЯைрои்родு ро╡ீроЯு родிро░ுроо்рокுроХிро▒ாро░். родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ рокிро▒роХு роиро▓்ро╡ாро┤்ро╡ை рокாродிроХ்роХுроо் роЪிро▓ роиிроХро┤்ро╡ுроХро│், роЪிро▓ ро╡ாро░роЩ்роХро│் рооро▒்ро▒ுроо் роЪிро▓ рооாродроЩ்роХро│ுроХ்роХுрок் рокிро▒роХு роЪிро▓ро░ுроХ்роХு роПро▒்рокроЯுроХிрой்ро▒рой. роХோро╡ிроЯ்-19родொро▒்ро▒ுроХ்роХாроХ рооро░ுрод்родுро╡рооройைропிро▓் роЪேро░்роХ்роХрок்рокроЯுроо் роиோропாро│ிроХро│் рокро▓ро░் роиீрог்роЯроХாро▓ роиோроп்роХро│ை роЙроЯைропро╡ро░்роХро│். роЖройாро▓ுроо் ро▓ேроЪாрой роЕро▒ிроХுро▒ிроХро│் роЗро░ுрои்родு родொро▒்ро▒ிро▓் роЗро░ுрои்родு рооீрог்роЯ роиோропாро│ிроХро│் роЪிро▓ро░் роХூроЯ ро╡ைро░ро╕ிрой் роиீрог்роЯроХாро▓ ро╡ிро│ைро╡ுроХро│ாро▓் рокாродிроХ்роХрок்рокроЯ ро╡ாроп்рок்рокு роЙро│்ро│родு. роЪிро▓ роиீрог்роЯроХாро▓ ро╡ிро│ைро╡ுроХро│் роХроЯுрооைропாройродாроХро╡ுроо் ро╡ாро┤்ро╡ை рооுроЯроХ்роХுро╡родாроХро╡ுроо் роЗро░ுроХ்роХроХ்роХூроЯுроо். роЗрои்род роХோро╡ிроЯ்-19-роХ்роХுрок் рокிрои்родைроп роЪிроХிроЪ்роЪைроХ்роХாрой роЪிро▒рок்рокு рооро░ுрод்родுро╡рооройைроХро│், роиோропாро│ிроХро│ிрой் роЕро▒ிроХுро▒ிроХро│ை родொроЯро░்роЪ்роЪிропாрой роЕроЯிрок்рокроЯைропிро▓் роХрог்роХாрогிроХ்роХро╡ுроо் роЪро░ிропாрой роиேро░род்родிро▓் роЕро╡ро░்роХро│ுроХ்роХு роЙро░ிроп рооро░ுрод்родுро╡ роХро╡ройிрок்рокை ро╡ро┤роЩ்роХро╡ுроо் роЙродро╡ுроо்.” роОрой்ро▒ாро░்.

  роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│ிрой் родொро▒்ро▒ு роиோроп் роЪிроХிроЪ்роЪைрок் рокிро░ிро╡ிрой் рооூрод்род роЖро▓ோроЪроХро░் роЯாроХ்роЯро░் роЪுро░ேро╖் роХூро▒ுроХைропிро▓், “роХோро╡ிроЯ்-19 рокாродிрок்рокுроХ்роХு рооுрой்ройро░், роиாроЩ்роХро│் роПро▒்роХройро╡ே родொро▒்ро▒ா роиோроп்роХро│ிрой் (NCD) роЕродிроХро░ிрод்род рокாродிрок்рокுроХро│ை роОродிро░்роХொрог்роЯோроо். роЕро╡ை 70 роЪродро╡ீродрод்родுроХ்роХுроо் роЕродிроХрооாрой рооро░рогроЩ்роХро│ுроХ்роХு роХாро░рогрооாроХ роЗро░ுрои்родрой. родро▒்рокோродு роХோро╡ிроЯ் рокாродிрок்рокு роПро▒்рокроЯ்роЯுро│்ро│ роиிро▓ைропிро▓், роХோро╡ிроЯ்-19-роХ்роХுрок் рокிро▒роХு роЗрои்род роиோроп்род் родாроХ்роХроЩ்роХро│ிрой் ро╡ிро│ைро╡ுроХро│் роЕродிроХро░ிроХ்роХுроо். рооேро▓ுроо் роХூроЯுродро▓் роЪிро▒рок்рокு роХро╡ройроо் роЪெро▓ுрод்родாро╡ிроЯ்роЯாро▓், родொро▒்ро▒ுроиோропைрод் родாрог்роЯி роиோропுро▒்ро▒ родрой்рооை рооро▒்ро▒ுроо் роЗро▒рок்рокு роЕродிроХро░ிроХ்роХுроо் роиிро▓ை роПро▒்рокроЯроХ் роХூроЯுроо்.  роПро▒்роХெройро╡ே роиீрог்роЯ роХாро▓ роиோроп்роХро│் роЗро░ுрои்родро╡ро░்роХро│் роХோро╡ிроЯ்-19 родொро▒்ро▒ாро▓் рокாродிроХ்роХрок்рокроЯ்роЯு рооீрог்роЯிро░ுрои்родாро▓் роЕро╡்ро╡ாро▒ு рооро▒்ро▒ роиோроп்ро╡ாроп்рок்рокроЯ்роЯ роирокро░்роХро│் роЕродிроХ родொроЯро░் рокாродிрок்рокுроХро│ைрод் роЪрои்родிроХ்роХроХ் роХூроЯுроо். роЗрои்род роЪிро▒рок்рокு роХிро│ிройிроХ்роХுроХро│் роХோро╡ிроЯ்роЯு-роХ்роХு рокிрои்родைроп роиோроп்род் родрой்рооைропிрой் роХроЯுрооைропாрой ро╡ிро│ைро╡ுроХро│் рооேро▓ுроо் роЕродிроХро░ிрок்рокродைрод் родроЯுроХ்роХுроо். роиோропாро│ிропை рооைропрооாроХроХ் роХொрог்роЯ, ро╡ிро░ிро╡ாрой, родொро▓ைрод் родொроЯро░்рокு роЖро▓ோроЪройை рооро▒்ро▒ுроо் роХிро│ிройிроХ்роХிро▓் роиேро░роЯி роЕроЯிрок்рокроЯைропிро▓ாрой роЪிроХிроЪ்роЪைрод் родிроЯ்роЯрод்родிрой் рооூро▓роо் роХோро╡ிроЯ்-роХ்роХு рокிрои்родைроп роиோроп்род் родாроХ்роХрод்родிрой் роТро░ு рокроХுродிропாроХ роЙро░ுро╡ாроХுроо் роиாроЯ்рокроЯ்роЯ рокாродிрок்рокுроХро│ை родிро▒роо்рокроЯрод் родро╡ிро░்роХ்роХ роЗрои்род роЪிро▒рок்рокு роХிро│ிройிроХ்роХுро│் роЙродро╡ுроо்.” роОрой்ро▒ாро░்.

 рооுродро▓் роХроЯ்роЯрооாроХ, роЪெрой்ройை, роородுро░ை, ро╣ைродро░ாрокாрод், рокெроЩ்роХро│ூро░ு, рооைроЪூро░், роХொро▓்роХрод்родா, рокுро╡ройேро╕்ро╡ро░், роХுро╡ро╣ாрод்родி, роЯெро▓்ро▓ி, роЗрои்родூро░், ро▓роХ்ройோ, рооுроо்рокை рооро▒்ро▒ுроо் роЕроХроородாрокாрод் роЖроХிроп роироХро░роЩ்роХро│ிро▓் роХோро╡ிроЯ் родொро▒்ро▒ு рокாродிрок்рокுроХ்роХு роЪிроХிроЪ்роЪைропро│ிроХ்роХுроо் роЕрок்рокро▓்ро▓ோ рооро░ுрод்родுро╡рооройைроХро│ிро▓் роЗрои்род роХோро╡ிроЯ் роЪிроХிроЪ்роЪைроХ்роХுрок் рокிрои்родைроп родொроЯро░் роЪிроХிроЪ்роЪை рооைропроЩ்роХро│் роЙро░ுро╡ாроХ்роХрок்рокроЯுроо். роЗрои்родроХ் роХிро│ிройிроХ்роХுроХро│் роТро░ு роЪெро╡ிро▓ிропро░ிрой் роЙродро╡ிропுроЯрой் роТро░ு роХுроЯுроо்рок роиро▓ рооро░ுрод்родுро╡ро░ைроХ் роХொрог்роЯ роТро░ு рокிро░род்ропேроХ роХுро┤ுро╡ாро▓் роиிро░்ро╡роХிроХ்роХрок்рокроЯுроо்.

 рооுрой்рокродிро╡ுроХро│ுроХ்роХhttps://www.apollohospitals.com/роЗрогைроп родро│род்родைрок் рокாро░்ро╡ைропிроЯро╡ுроо் роЕро▓்ро▓родு 044-28293333роОрой்ро▒ роОрог்рогை роЕро┤ைроХ்роХро╡ுроо்.

Sunday, 29 September 2019

Apollo Hospitals Grouphost Futuring Cardiac Care Summit


Apollo Hospitals Grouphost‘Futuring Cardiac Care Summit’ to foster discussions on prevention and eradication of Heart Disease

~ Summit provides platform for stakeholders to come together
and develop action steps~


Apollo Hospitals Group hosted thefirst “Futuring Cardiac Care Summit” on 28th September in Chennai. The summit provides insights and perspectives that have the potential to transform the efforts towards prevention and eradication of heart disease.

Bringing together all stakeholders on a single platform, the Futuring Cardiac Care Summit brought together key partners, expert clinical consultants, prevention specialists and Apollo Hospitals’ leadership to develop targeted recommendations and specific action steps towards reversing the epidemic of heart disease. The summit brought to the fore the synergy between modern cardiac care delivery and technology adoption for a disease free India.


Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group,said, “Cardiovascular disease is one of the major NCDs and the leading cause of death with India having the highest burden of cardiovascular disease in the world. We need to acknowledge this crisis and take urgent action to prevent and reverse the rise in cardiovascular diseases. The Futuring Cardiac Care Summit is an important step in this direction, and provides a platform to bring together the physician and public health community to develop targeted recommendations and specific action steps. This summit is a beginning to initiate a systemic process for developing possible outcomes and planning for the future.  Apollo team, as a futurist is willing to explore changes and innovate with you. Together, we will free INDIA from cardiac disease!”

The two highlights of the summit were:
·         Apollo Hospitals Group sign MoU with Wellysis to set up joint venture in Chitoor, Andhra Pradesh:
Apollo Hospitals Group and Wellysis a spinoff company of Samsung SDS South Korea have signed anMoU to develop, manufacture and commercialise cardiac wellness, diagnostic, monitoring and therapeutic devices, which would have a positive impact on people across the world.
The joint venture will be set up in Chitoor, Andhra Pradesh. The MoU was exchanged by Mr.Rick Hongryul Kim, CTO/CMO & Co-Founder, Wellysis; and Dr.Hari Prasad, Group President, Apollo Hospitals Group; in the august presence of Dr.Prathap C. Reddy, Chairman, Apollo Hospitals Group.

·         Demonstration of Cardiac Command Centre:
The demonstration of the Cardiac Command Centre with modern connected technologies enabling Tele ECH Monitoring, CICU monitoring, Tele ECHO Monitoring ,Remote Cathlab and ER Response Module. The Cardiac Command Centre will also have facilities for training and development, and a management dashboard for tracking and control. Over 40 such command centres are already live across Apollo Hospitals Group. Any doctor across the country can register for the Command Centre and gain access to the knowledge and experience of over 300 cardiologists across Apollo Hospitals’ ecosystem.

Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, said, “There has been a massive increase in deaths due to heart diseases in the last three decades. Our country has only 4,000 cardiologists as compared to the 88,000 that we should ideally have. It is a huge gap to cover and the best way to start covering this gap is through technology. The goal of this initiative is to come together, witness, discuss and learn from each other new ways of addressing cardiology. Robotics, AI, Tele-cardiology… these are some things we know happening today.  But do we experience how these innovations are applied to our practice? How we can use and potentially leverage them to create new innovations, processes, & future that we are not thinking today. We hope this summit will help open-up such foresights and possibilities that will lead to a cardiac disease free world. The Cardiac Command Centre with high end screening tools along with the National Cardiac Registry will form the foundation of the battle against cardiovascular diseases.”

“Aspects of the cardiovascular diseases epidemic in India are particular causes of concern, including its accelerated build-up, early age of disease onset in the population, and missing out on cases due to misdiagnosis and under-reporting of CVD and the high case fatality rate. The Cardiac Command Centreprovides a great opportunity to physicians in Urban & Sub-urban settings, Standalone clinics/nursing homes, National/State Medical Associations, Government Institutions, and New-Age Start-ups in cardiovascular space to join this network and gain access to knowledge and experience of over 300 cardiologists across the Apollo ecosystem to save precious lives,” addedMs. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group.

AgimBeshiri, M.D., Senior Medical Director, Global Medical and Scientific Affairs for Abbott's diagnostics business said, “Abbott collaborates with likeminded partners to improve cardiac health outcomes worldwide. We are pleased to work with Apollo to set up a national cardiac registry that helps in assessing risk of cardiac events potentially years in advance. Abbott’s life-changing technology has the potential to transform how doctors identify those at risk for developing heart disease because our diagnostic test uses a biomarker specific to the heart. We’d like to congratulate Apollo Hospitals on building a powerful platform that combines healthcare and various technological innovations that have the potential to change the way cardiac diseases will be treated in future.”

“We are pleased to partner with Apollo Hospitals for the FUTURING cardiac care. Together, we created a process to connect a century old life-saving technology – ECG between patient, local General practitioner, and an expert cardiologist at the Apollo Command Centre. During our pilot run, we could guide 25000 patients from as far away as 2000 KM from the centre during chest pain, guide general practitioners to provide appropriate care to patients and provide timely support and intervention to save 250 of them who were going through acute MI,” said S Ganesh Prasad, Managing Director, GenWorks Health Pvt Ltd., a Wipro GE Healthcare invested company.
  
“At Genworks we believe that we have to build a strong, connected eco-system – doctor at the point of care, patient, specialist at super hospitals and technology can make it happen and save lives. Our vision is to take technology and process as this to every physician in any part of the country to be able to intervene in times of need and save lives,”addedGanesh Prasad.

The Futuring Cardiac Care Summit, organised with support from partners including GenWorks, Abbott and HealthNet Global,  is a one of kind platform with an objective to eradicate the high risks of cardiovascular and its affinity towards the future generations and finding integrated solutions to screen and detect such complications in a more efficient way.

For more information about the Cardiac Command Centre and the Futuring Cardiac Care Summit, log on to www.futuringcardiology.com

Monday, 27 August 2018

APOLLO HOSPITALS Workshop for doctors Detection and management of child abuse

APOLLO HOSPITALS Workshop for doctors Detection and management of child abuse

Apollo Hospitals group, Asia’s largest and most trusted multi-specialty chain of hospitals today organised a one day workshop for the doctor’s fraternity on “Detection and Management of Child Abuse” at Apollo Children’s Hospital. The workshop was inaugurated by Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group. 

Apollo Hospitals group, Asia’s largest and most trusted multi-specialty chain of hospitals today organised a one day workshop for the doctor’s fraternity on “Detection and Management of Child Abuse” at Apollo Children’s Hospital. The workshop was inaugurated by Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group.
The joint conference by Apollo Children’s hospital and TULIR (Ngo) is a forum for presentations and discussions about multi-disciplinary efforts to investigate, treat and eradicate clinical issues during detection and treatment of child abuse.
Child abuse is a serious social issue with high morbidity and mental stress; worldwide, 155 000 deaths occur annually in children as a result of abuse or neglect. 


1 Preventing recurrent abuse or recognizing early abuse is difficult but essential if long-term effects are to be limited. Although victims of child abuse have higher emergency department use than the general pediatric population, child abuse unfortunately often remains unrecognized in the emergency department. Implementing a uniform screening protocol for child abuse in emergency departments could increase detection rates, leading to a decrease in the short- and long-term effects of child abuse.
Dr.Jagadeesh Narayan Reddy, a Professor of Forensic Medicine & Toxicology of Vydehi Institute of Medical Sciences & Research Centre, Bangalore and Ms.Vidya Reddy, TULIR addressed the seminar where the Government policies and legal implications of CSA were explained to the medical fraternity.